ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 104.2% in June

ReShape Lifesciences Inc. (NASDAQ:RSLS) saw a large increase in short interest in June. As of June 30th, there was short interest totalling 462,400 shares, an increase of 104.2% from the June 15th total of 226,500 shares. Based on an average trading volume of 6,160,000 shares, the days-to-cover ratio is presently 0.1 days. Approximately 2.2% of the shares of the stock are short sold.

ReShape Lifesciences Stock Performance

NASDAQ:RSLS opened at $0.22 on Friday. ReShape Lifesciences has a fifty-two week low of $0.14 and a fifty-two week high of $1.66. The company has a fifty day moving average of $0.20 and a two-hundred day moving average of $0.20.

ReShape Lifesciences (NASDAQ:RSLS) last issued its quarterly earnings results on Wednesday, May 15th. The medical device company reported ($0.09) earnings per share for the quarter. ReShape Lifesciences had a negative net margin of 130.99% and a negative return on equity of 207.78%. The company had revenue of $1.94 million during the quarter.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.